Quintiles Transitional Holdings Inc. (Q) Given New $110.00 Price Target at Jefferies Group LLC

Quintiles Transitional Holdings Inc. (NYSE:Q) had its price target boosted by Jefferies Group LLC from $107.00 to $110.00 in a report published on Monday morning. They currently have a hold rating on the medical research company’s stock.

Other equities analysts also recently issued research reports about the stock. Barclays PLC reissued an overweight rating and issued a $98.00 price objective (up previously from $90.00) on shares of Quintiles Transitional Holdings in a report on Monday, July 17th. Stifel Nicolaus raised shares of Quintiles Transitional Holdings from a hold rating to a buy rating and raised their price objective for the stock from $92.00 to $128.00 in a report on Friday. Royal Bank Of Canada assumed coverage on shares of Quintiles Transitional Holdings in a report on Tuesday, September 19th. They issued an outperform rating and a $116.00 price objective on the stock. Citigroup Inc. raised their price objective on shares of Quintiles Transitional Holdings from $96.00 to $97.00 and gave the stock a neutral rating in a report on Monday, August 7th. Finally, William Blair raised shares of Quintiles Transitional Holdings from a market perform rating to an outperform rating and raised their price objective for the stock from $70.10 to $93.42 in a report on Friday, August 4th. Eight investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Quintiles Transitional Holdings has a consensus rating of Buy and a consensus price target of $101.64.

Quintiles Transitional Holdings (NYSE Q) traded up 0.87% during mid-day trading on Monday, hitting $108.10. 1,389,339 shares of the stock traded hands. The stock has a market cap of $23.41 billion, a price-to-earnings ratio of 313.33 and a beta of 0.62. The company’s 50 day moving average price is $97.91 and its 200-day moving average price is $90.89. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $108.81.

Quintiles Transitional Holdings (NYSE:Q) last posted its quarterly earnings data on Thursday, October 26th. The medical research company reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.14 by $0.05. The company had revenue of $2.02 billion for the quarter, compared to the consensus estimate of $2.01 billion. Quintiles Transitional Holdings had a net margin of 0.58% and a return on equity of 12.60%. The firm’s revenue was up 77.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.00 earnings per share. Analysts predict that Quintiles Transitional Holdings will post $4.61 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This article was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://www.com-unik.info/2017/10/31/quintiles-transitional-holdings-inc-q-given-new-110-00-price-target-at-jefferies-group-llc.html.

In other news, Director Dennis B. Ph D. Gillings sold 968,023 shares of Quintiles Transitional Holdings stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $97.33, for a total transaction of $94,217,678.59. Following the sale, the director now owns 9,071,839 shares in the company, valued at $882,962,089.87. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Ari Bousbib sold 92,160 shares of Quintiles Transitional Holdings stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the sale, the insider now owns 1,082,919 shares in the company, valued at approximately $97,841,731.65. The disclosure for this sale can be found here. Insiders have sold 14,208,382 shares of company stock worth $1,362,839,475 in the last ninety days. Insiders own 6.40% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in shares of Quintiles Transitional Holdings by 2.2% during the second quarter. Vanguard Group Inc. now owns 12,789,723 shares of the medical research company’s stock valued at $1,144,680,000 after buying an additional 280,893 shares during the last quarter. KBC Group NV raised its position in shares of Quintiles Transitional Holdings by 53.3% during the second quarter. KBC Group NV now owns 18,959 shares of the medical research company’s stock valued at $1,697,000 after buying an additional 6,591 shares during the last quarter. Key Square Capital Management LLC bought a new stake in shares of Quintiles Transitional Holdings during the second quarter valued at approximately $2,738,000. AXA raised its position in shares of Quintiles Transitional Holdings by 85.4% during the second quarter. AXA now owns 251,830 shares of the medical research company’s stock valued at $22,539,000 after buying an additional 115,993 shares during the last quarter. Finally, TIAA CREF Investment Management LLC raised its position in shares of Quintiles Transitional Holdings by 5.4% during the second quarter. TIAA CREF Investment Management LLC now owns 832,571 shares of the medical research company’s stock valued at $74,515,000 after buying an additional 42,733 shares during the last quarter. Hedge funds and other institutional investors own 93.03% of the company’s stock.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

What are top analysts saying about Quintiles Transitional Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Quintiles Transitional Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit